Milestone Pharmaceuticals Stock (NASDAQ: MIST) stock price, news, charts, stock research, profile.
You can purchase shares of Milestone Pharmaceuticals (NASDAQ:MIST) through any online brokerage.
Other companies in Milestone Pharmaceuticals’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Iterum Therapeutics (NASDAQ:ITRM), Bioage Labs (NASDAQ:BIOA), Rani Therapeutics Hldgs (NASDAQ:RANI) and Telomir Pharmaceuticals (NASDAQ:TELO).
Milestone Pharmaceuticals has a consensus price target of $10.83.
The stock price for Milestone Pharmaceuticals (NASDAQ: MIST) is $1.73 last updated December 23, 2024 at 4:55 AM EST.
There are no upcoming dividends for Milestone Pharmaceuticals.
Milestone Pharmaceuticals’s Q4 earnings are confirmed for Thursday, March 20, 2025.
There is no upcoming split for Milestone Pharmaceuticals.
Milestone Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.